How 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy
An analysis of more than 10,000 gliomas and clinical outcomes found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.
from Latest Science News -- ScienceDaily https://ift.tt/34Lwcy7
from Latest Science News -- ScienceDaily https://ift.tt/34Lwcy7
0 Response to "How 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy"
Post a Comment